Sun Pharma Share Price Target And Prediction 2025-30

Sun Pharma Share Price Target : Although there are lakhs of shares listed in the stock market, today we are going to tell you about such a stock which can go up a lot in the coming time. This article will provide more details about Sun Pharma Share Price Target 2025, 2026 to 2030.

Today’s blog is Sun Pharma Share Price Target And Prediction 2025-30 : Complete Analysis, by reading which you can take your investment decision. Read the Sun Pharma Target Share Price 2025-30 blog carefully so that you do not miss any information…

Sun Pharma : About Company

Sun Pharmaceutical Industries Limited is an India-based specialty generic pharmaceutical company. The company is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and active pharmaceutical ingredients (APIs). It manufactures a broad, diverse and complementary portfolio of generic and specialty medicines targeting a wide range of chronic and acute treatments.

The company’s vertically integrated network enables it to produce a wide range of pharmaceuticals including oncology, hormones, peptides and steroidal drugs. The company also has a product portfolio in the RoW markets, which includes injectables, hospital products and retail products.

It offers a wide range of dosage forms including orals, creams, ointments, injectables, sprays and liquids. Its marketed specialty portfolios include Illumya/Illumatri, Winlevi, Levulan Kerastique + BLU-U, Absorica LD, Odomzo, Cequa, Bromsite, Xelpros, Yonsa, Cezabi, and the Sprinkle Portfolio.

Now let’s take a look at Sun Pharma Share Price Target And Prediction 2025-30…

Year	Target
2025	2,096
2026	2,506
2027	2,996
2028	3,581
2029	4,281
2030	5,118

Now let’s take a look at the company’s fundamentals to get more details on Sun Pharma Target Share price …

Fundamental	Data
Market Cap	4,04,900 Cr.
P/E Ratio	35.42%
P/B Ratio	5.86%
Industry P/E	32.80%
Debt To Equity	0.04
ROE	15.99%
EPS (TTM)	47.65
Div. Yield	0.80%
Book Value	288.06
Face Value	1

Now to know Sun Pharma Share Price Target in more detail, we take a look at the financial position of the company for the last 5 years and this data is according to Groww.in…

Company Revenue

Year	Revenue (In Crore)
2020	33,489
2021	34,357
2022	39,730
2023	44,394
2024	49,887

Company Profit

Year	Profit (In Crore)
2020	4,187
2021	2,285
2022	3,406
2023	8,561
2024	9,648

Company Net Worth

Year	Net Worth (In Crore)
2020	49,125
2021	49,480
2022	51,066
2023	59,315
2024	67,106

Now let’s take a look at the company’s Strengths And Limitations to get more details on Sun Pharma target share price and this data is according to Ticker.finology.in…

Strengths	Limitations
The company has shown a good profit growth of 50.26% for the Past 3 years.	The company has shown a poor revenue growth of 12.83% for the Past 3 years.
The Company has been maintaining an effective average operating margins of 21.75% in the last 5 years.	Company has a poor ROE of 6.22% over the past 3 years.
The company has an efficient Cash Conversion Cycle of 23.28 days.	Company has negative cash flow from operations of -292.42.
Company has a healthy liquidity position with current ratio of 3.36.	The company is trading at a high PE of 130.50.
The company has a high promoter holding of 54.48%.	The company is trading at a high EV/EBITDA of 68.71.

Now take a look at Sun Pharma Share Price Target’s share price. Many factors affect it…

Global Demand

Sun Pharma’s leadership in generic medicines ensures a steady demand for its products, boosting its revenue and share price.

Specialty Drugs

The company’s move towards specialty drugs in areas such as dermatology and oncology has boosted its growth prospects.

Strong R&D Investments

Significant investments in research and development enable Sun Pharma to launch innovative products, boosting investor confidence.

Regulatory Approvals

Approvals from the US FDA and other regulatory bodies play a key role in determining the company’s growth and share price.

Currency Exchange Rates

As a major exporter, fluctuations in the value of the Indian rupee against global currencies can impact revenue and profitability.

Based on the Sun Pharma Share Price Target And Prediction 2025-30 : Complete Analysis blog, it can be said that Sun Pharma has consistently proven itself to be a market leader in India and globally. With its focus on specialty drugs, strong R&D investments and strong financial performance, it is an attractive stock for long-term investors.

According to data from Ticker.finology.in the company has shown good profit growth of 50.26% in the last 3 years. The company has been maintaining an effective average operating margin of 21.75% in the last 5 years. The company has an efficient cash conversion cycle of 23.28 days.

Disclaimer : We are Not SEBI Registered and this article is for informational purposes only. The views and recommendations expressed above are those of individual analysts and not FactBeez. We advise investors to check with certified experts before making any investment decision which will help you make informed decisions and reduce the chances of losses.

Comments

Leave a Reply Cancel reply

Contents

Sun Pharma : About Company